Logo Loading...

Phone: +91 7499180452


Artificial Intelligence (AI) in drug discovery Industry

According to Minds Insights Global Artificial Intelligence (AI) in Drug Discovery Market is expected to register CAGR 38.9% during the assessment period from 2020 to 2025 and expected to hold a market value of USD 1575 million in 2025.

Market Definition – 

Artificial intelligence can help expand the drug discovery universe by making predictions in more novel areas of biology and chemistry. By extracting text from scientific papers, AI can help identify relevant information faster and make links between biomedical entities, such as medicines and proteins, often with relatively little information.

In vitro fertilization (IVF) is a complex set of procedures that helps with fertility or prevent genetic problems and assist with childbirth.

Market Dynamics - The growth of the global artificial intelligence (AI) in drug discovery market is attributed to requirement of controlling cost and time of drug discovery & development, patent expiration similarly, rising cross-industry collaborations boosting the growth of the market.

However, rising biotechnology industry and emerging markets restraining the growth of the market.

Key Market Players - The key market players of market are Envisagenics (US), IBM Corporation (US), Numedii (US), Microsoft (US), Numerate (US), Google (US), BIOAGE (US), NVIDIA Corporation (US), Cyclica (Canada), Atomwise, Inc. (US), Exscientia (UK), Deep Genomics (Canada), Benevolent AI (UK), Cloud Pharmaceuticals (US), Insilico Medicine (US) among others.

Segmental Analysis – 

The global artificial intelligence (AI) in drug discovery market is divided by technology, offering, application, and region.

Based on technology the market is divided into machine Learning and others. Machine Learning segment is subdivided into deep learning, reinforcement learning, supervised learning, unsupervised learning and others. Based on offering the market is further bifurcated into software and services. Based on application the market is further bifurcated into cardiovascular diseases, immuno-oncology, neurodegenerative diseases, metabolic diseases, and others. Based on end-use, the market further divided into pharmaceutical & biotechnology companies, research centers and academic & government institutes, and contract research organizations.

Regional Analysis - The global Artificial Intelligence (AI) in Drug Discovery market is divided into four main regions Americas, Europe, Asia-Pacific, and Middle East and Africa. America is further divided into North America and Latin America. North America is again divided into the US and Canada.

Key Questions Answered In the Report – 

What was the size of the market in 2014-2018?

What will be the market growth rate and market size in the forecast period 2019-2025?

What are the market dynamics and market trends?

Which segment and region will lead the market in the forecast period?

Which are the key market players, competitive landscape and key development strategies of them?

Recent Market Updates

The market development occurs through new product launch, strategic mergers, acquisition, joint ventures, and agreements.  The following are the recent key market developments.